Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Effect of Two Doses of Olmesartan Medoxomil and Amlodipine on Vascular Markers in Hypertensive Patients With Metabolic Syndrome

Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company · 2008
ClinicalTrials.gov · Datasets · License: Public Domain · 2008
Open Source ↗
hypertensionmetabolic-syndrome
metabolic syndrome, hypertension, inflammatory markers, vascular protection, om effect, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 859992
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.